SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1929 |
Sector | Life Science |
Employees | 5,325 |
Revenue | 3.3B EUR (2023) |
Ipsen is a research and development pharmaceutical company. It manufactures specialty pharmaceuticals and has a worldwide sales presence. Ipsen focuses on products in the gastro-enterology, neurology and cardiovascular therapeutic areas and has also developed specific expertise in some biotech niches such as endocrinology, oncology, neurology and hematology. Ipsen was founded in 1929 and is based in Boulogne-Billancourt, France.
DEAL STATS | # |
---|---|
Overall | 11 of 11 |
Sector (Life Science) | 11 of 11 |
Type (Add-on Acquisition) | 8 of 8 |
State (Massachusetts) | 3 of 3 |
Country (United States) | 5 of 5 |
Year (2023) | 1 of 1 |
Size (of disclosed) | 1 of 5 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-06-27 |
Epizyme
Cambridge, Massachusetts, United States Epizyme is a clinical stage biopharmaceutical company creating personalized therapeutics for patients with genetically defined cancers. Epizyme was founded in 2007 and is based in Cambridge, Massachusetts. |
Buy | $247M |